Patent · US Active

Pyrrolotriazine compounds and methods of inhibiting TAM kinases

US11040981B2 · kind B2 · utility

0Cited by
1References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2018
Grant dateJun 22, 2021
Priority date
Expiry dateOct 9, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.